Future Medicine  Co., Ltd. Logo

Future Medicine Co., Ltd.

Develops nucleoside-based synthetic drugs for antiviral and anticancer applications.

341170 | KO

Overview

Corporate Details

ISIN(s):
KR7341170009
LEI:
Country:
South Korea
Address:
경기도 성남시 수정구 창업로 54 619호, 성남시

Description

Future Medicine Co., Ltd. is a new drug development company specializing in nucleoside-based synthetic drugs. The company focuses on creating therapeutics for diseases with high unmet medical needs, particularly in antiviral and anticancer applications. Its primary pipeline candidate, FM101, is an anti-inflammatory and anti-fibrotic agent being investigated for the treatment of conditions such as non-alcoholic steatohepatitis (NASH), diabetic nephropathy, and primary biliary cholangitis (PBC). The company has also conducted research and filed patents for therapeutics related to coronaviruses.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-06-23 00:00
기업설명회(IR)개최결과
Korean 6.6 KB
2025-06-17 00:00
본점소재지변경
Korean 5.1 KB
2025-06-09 00:00
기업설명회(IR)개최
Korean 7.0 KB
2025-03-28 00:00
정기주주총회결과
Korean 20.7 KB
2025-03-28 00:00
사외이사의선임ㆍ해임또는중도퇴임에관한신고
Korean 9.9 KB
2025-03-20 00:00
감사보고서제출
Korean 16.0 KB
2025-03-20 00:00
사업보고서 (2024.12)
Korean 333.9 KB
2025-03-13 00:00
주주총회소집공고
Korean 164.6 KB
2025-03-13 00:00
주주총회소집결의
Korean 10.8 KB
2025-03-13 00:00
주주총회집중일개최사유신고
Korean 5.1 KB
2024-12-16 00:00
주주명부폐쇄기간또는기준일설정
Korean 4.1 KB
2024-12-06 00:00
[기재정정]주식매수선택권부여에관한신고
Korean 22.8 KB
2024-11-29 00:00
기업설명회(IR)개최결과
Korean 6.6 KB
2024-11-21 00:00
기업설명회(IR)개최
Korean 7.0 KB
2024-07-19 00:00
[기재정정]주식매수선택권부여에관한신고
Korean 23.0 KB

Automate Your Workflow. Get a real-time feed of all Future Medicine Co., Ltd. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Future Medicine Co., Ltd.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Future Medicine Co., Ltd. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

4BASEBIO PLC Logo
Manufactures GMP-grade synthetic DNA for next-generation therapeutics and vaccines.
United Kingdom
4BB
4D Molecular Therapeutics, Inc. Logo
Develops genetic medicines using AAV vectors for ophthalmology and pulmonology diseases.
United States of America
FDMT
4SC AG Logo
Biopharmaceutical company with no products under development or operational business.
Germany
VSC
60 DEGREES PHARMACEUTICALS, INC. Logo
Develops and commercializes medicines for infectious diseases, focusing on tropical illnesses.
United States of America
SXTP
89bio, Inc. Logo
Clinical-stage biopharma developing therapies for liver and cardiometabolic diseases.
United States of America
ETNB
Aardvark Therapeutics, Inc. Logo
Clinical-stage biopharma developing therapeutics for hunger and metabolic diseases.
United States of America
AARD
ABBOTT LABORATORIES Logo
Global healthcare company in medical devices, diagnostics, nutrition & pharmaceuticals.
United States of America
ABT
AbbVie Inc. Logo
A research-based biopharmaceutical company developing and manufacturing medicines.
United States of America
ABBV
AbCellera Biologics Inc. Logo
Discovers and develops antibody-based therapeutics using a proprietary platform.
United States of America
ABCL
Develops antibody-based therapeutics using CAR-T, NEST, and AffiMab platforms.
South Korea
174900

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.